Advertisement
Home »

Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer.

Feb 05, 2024

ABOUT THE EXPERTS

  • Ravi K Goyal

    RTI Health Solutions, Research Triangle Park, NC, USA.

    Jingchuan Zhang

    Eisai Inc, Nutley, NJ, USA.

    Keith L Davis

    RTI Health Solutions, Research Triangle Park, NC, USA.

    Martina Sluga-O’Callaghan

    RTI Health Solutions, Research Triangle Park, NC, USA.

    Peter A Kaufman

    Larner College of Medicine, Division of Hematology/Oncology, University of Vermont Cancer Center, 111 Colchester Avenue, EP2, Burlington, VT, 05401, USA. Peter.Kaufman@uvmhealth.org.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement